Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bone marrow mesenchymal stem cells plus hyaluronic acid for knee osteoarthritis
2009-017624-72Phase 2Completed
- Sponsor
- Cima Universidad de Navarra
- Start
- Dec 2010
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of autologous bone-marrow mesenchymal stem cells and hyaluronic acid in knee osteoarthritis (OA) and osteoarthritis (OA) (3 arms), sponsored by Cima Universidad de Navarra. Primary endpoints: Safety and feasibility, Clinical pain and function and 1 more. Started Dec 2010; status: completed.
02
Drugs
autologous bone-marrow mesenchymal stem cellshyaluronic acid
03
Conditions
knee osteoarthritis (OA)osteoarthritis (OA)
Beyond the preview
Go deeper on 2009-017624-72.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017624-72.